A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Why the study?
What are the contemporary management patterns and guideline compliance for atrial fibrillation in ESC member countries?
Population
Patients with atrial fibrillation managed by cardiologists in European Society of Cardiology member countries
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
Highlights gaps in AF anticoagulation adherence; leaves open optimal strategies to boost NOAC uptake in ESC countries.
Key Points
- The aim is to evaluate the management and treatment of atrial fibrillation by cardiologists in Europe.
- Prospective survey conducted among ESC member countries
- Collection of data on oral anticoagulant usage and compliance with treatment guidelines
- Oral anticoagulant usage increased, yet novel OAC use remained low
- Compliance with treatment guidelines is suboptimal for patients with low and high stroke risk scores
Structured PICO
What are the contemporary management patterns and guideline compliance for atrial fibrillation in ESC member countries?
P
Population
Patients with atrial fibrillation managed by cardiologists in European Society of Cardiology (ESC) member countries
I
Intervention
Contemporary management and treatment of atrial fibrillation (observational registry)
O
Outcome
Oral anticoagulant use and compliance with treatment guidelines
Baseline results from the EORP-AF Pilot Registry demonstrate that despite increased overall oral anticoagulant use, novel OAC uptake is low and guideline adherence remains suboptimal.
Cite This Study
Lip et al. (2013) studied this question.